Real-World Data Collection of GORE Devices Used In the Endovascular Treatment of Aortic Aneurysms Which Incorporate Visceral Arteries.
NCT07480395 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2026-06-01
Summary
The registry population consists of patients presenting with complex aortic pathologies amenable to endovascular aortic repair that requires the incorporation of bridging stents to maintain visceral artery perfusion
Conditions
- Complex Aortic Aneurysms
- Thoracoabdominal Aneurysm
- Fenestrated Endovascular Aortic Repair
- Endovascular Aortic Repair
- Abdominal Aorta Aneurism
- Chronic Dissection
Sponsors & Collaborators
-
W.L.Gore & Associates
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-12-31
- Primary Completion
- 2031-12-31
- Completion
- 2035-12-31
More Related Trials
-
Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement
NCT01531374 ·Status: COMPLETED ·Phase: NA
-
Multi Modal Cardiac Imaging Prior Transcatheter Aortic Valve Implantation
NCT01805739 ·Status: RECRUITING
-
CoreValve Advance International Post Market Study
NCT01074658 ·Status: COMPLETED
-
Change in Coronary Microcirculation and FFR After TAVI in Patients With Cardiovascular Comorbidities
NCT04663334 ·Status: COMPLETED
-
Feasibility, Safety, and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic Stenosis
NCT06212050 ·Status: ENROLLING_BY_INVITATION
-
HAART Annuloplasty Device Valve Repair Registry
NCT04035356 ·Status: TERMINATED
-
The TransCatheter Valve and Vessels Trial
NCT03424941 ·Status: COMPLETED ·Phase: NA
-
TAVR: The Impact of Prothesis Positioning on Valvular and Coronary Hemodynamics
NCT06896227 ·Status: RECRUITING ·Phase: NA
-
accuRate Evaluation of Benefit With Optimal Medical Treatment With or Without Transcatheter Valve Repair of PARADOXical Low Flow Low Gradient Aortic Stenosis
NCT03863132 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Clinical and CPET Parameters That Predict Improvement in Functional Capacity After TAVI
NCT06833762 ·Status: RECRUITING
-
Outcome Prediction in Patients With Aortic Stenosis After TAVI
NCT06043180 ·Status: NOT_YET_RECRUITING
-
Transfemoral TAVI With or Without Coronary Angiogram in Patients With Severe Aortic Stenosis (PURE TAVI)
NCT06898086 ·Status: RECRUITING ·Phase: NA
-
Aortic Stenosis - Prognosis, Risk and Outcomes
NCT06863883 ·Status: NOT_YET_RECRUITING
-
Image Fusion and Calcification Raising in Trans Aortic Valve Implantation
NCT03247465 ·Status: WITHDRAWN ·Phase: NA
-
TAVIS Registry - Trilogy Heart Valve System for Management of Patients With Aortic Valve Disease
NCT05536310 ·Status: NOT_YET_RECRUITING
-
Clinical Outcomes of Patients Undergoing CABG Surgery With VEST Supported Venous Grafts
NCT04761068 ·Status: RECRUITING
-
Transapical Transcatheter Treatment Versus Conventional Surgery in Patients With Native Aortic Valve Stenosis
NCT00986193 ·Status: TERMINATED ·Phase: NA
-
Treatment of Aortic Stenosis in Brazil: Cost-Utility Analysis of TAVI vs SAVR
NCT04067089 ·Status: UNKNOWN ·Phase: NA
-
CoreValve® System Australia/New Zealand Clinical Study
NCT01015612 ·Status: COMPLETED ·Phase: NA
-
CHANGE Neo™ TA Registry With ACURATE Neo™ Aortic Bioprosthesis and ACURATE Neo™ TA Transapical Delivery System
NCT03454360 ·Status: TERMINATED
-
Randomized Trial of TAVI vs. SAVR in Patients With Severe Aortic Valve Stenosis at Low to Intermediate Risk of Mortality
NCT03112980 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
TAVR for Aortic Valve Disease
NCT05439863 ·Status: RECRUITING
-
Short-term Clinical Follow-up of the Vascular Closure Device MANTATM in Minimally Invasive Cardiac Surgery
NCT04802200 ·Status: COMPLETED
-
Neurocognitive Assessment in TAVI
NCT06120946 ·Status: COMPLETED
-
Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement
NCT01675440 ·Status: COMPLETED